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AbstrAct
Objectives Few studies have estimated the effect of 
diabetes integrated care at a population level. We have 
assessed the impact of introducing a community service-
led diabetes integrated care programme on commissioner 
payments (tariff) for inpatient care in rural England.
Methods The Diabetes Integrated Care Initiative was 
delivered by a separate enhanced community diabetes 
service, increasing specialist nursing, dietetic, podiatry and 
medical support to primary care and patients, while linking 
into other diabetes specialist services. Commissioner data 
were provided by the local authority. The difference in 
area between the two overlapping distribution curves of 
inpatient payments at baseline and follow-up (at 3 years) 
was used to estimate the effect of integrated care on 
commissioner inpatient payments on a population level.
results Over the 3-year period, reduced inpatient 
payments occurred in 2.7% (1.3% to 5.8%) of patients 
with diabetes aged more than 70 years in the intervention 
area. However, reduced diabetes inpatient payments 
occurred in 3.20% (1.77% to 7.20%) of patients aged <70 
years and 4.1% (2.3% to 7.9%) of patients ≥70 years in 
one of the two adjacent areas.
conclusion This enhanced community diabetes services 
was not associated with substantially reduced inpatient 
payments. Alternative diabetes integrated care approaches 
(eg, with direct primary and secondary care collaboration 
rather than with a community service) should be tested.
IntrOductIOn
As the social and economic impact of diabetes 
grows, so does the variety of attempts to 
improve care quality and reduce healthcare 
costs among those affected.1–4 One approach, 
which is able to provide at least equivalent care 
to routine medical care with some types of 
patients, has been the introduction of nurses 
working within protocols, within medical 
services.5 Other models known as ‘interme-
diate care’, including general practitioners 
with a special interest,6 and community 
diabetes nursing services6 have been imple-
mented, but without robust evaluation. As a 
proposed system, integrated care articulates 
all health workers and health systems around 
the needs of each patient and should be asso-
ciated with improved outcomes and less cost.7 
However, the impact of a population-based 
integrated care intervention is difficult 
to measure on an individual level. One 
randomised trial of an intermediate care 
service achieved minimal actual incre-
mental benefit.8 By their nature, randomised 
controlled trials are difficult to use when 
assessing the impact of a complete system 
change at a population level. Sarkadi et al 
have proposed a method to look at popula-
tion outcomes in their own right in the quest 
of understanding how interventions work 
at a population level.9 Under the English 
National Health Service (NHS), public inpa-
tient care is paid for from taxation through 
local commissioners. These payments do not 
generally cover the hospital costs of inpatients 
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strengths and limitations of this study
 ► The ‘health gain’ in the revised method was clearly 
defined with a formulated algorithm of evaluation, 
which broadened the utilisation scenarios especially 
when negative values were raised.
 ► The data used in this study depended on the 
completeness of the coding for diabetes in the 
general  practitioner records. The impact of this 
potential ascertainment bias should have been 
steady as no systematic change in coding was 
known to have occurred over this time period. 
 ► Data on some important confounders such as lipid 
profiles were not available in this study. 
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with diabetes,10 but can provide an NHS commissioner 
perspective that reflects both acuity and complexity, 
beyond, for example, length of stay. We have now used 
the Sarkadi approach to assess whether any changes in 
population-based commissioner inpatient payment data 
occurred during a diabetes integrated care intervention 
by viewing the level and distribution of commissioner 
inpatient payments in the population as the unit of 
interest.
MethOds
East Cambridgeshire and Fenland (ECF: 2009 population 
160 000, diabetes population 7790) is largely rural, with 
a small number of socioeconomically deprived commu-
nities.6 There is no local major hospital (with, eg, an 
emergency department) falling within the catchment 
areas of four hospitals outside of the area. Some diabetes 
outcomes have been historically poor.11 A separate, local, 
diabetes specialist nurse-led community service was intro-
duced in 2003.12 From April 2009, this was replaced with 
a new Diabetes Integrated Care Initiative (DICI) using 
additional finance (£250 000 pa), in an attempt to address 
continuing health disparities. The components of the 
DICI have been described in the previous publications.13 
The health district includes two other areas, Huntingdon-
shire and Greater Cambridge, which did not receive the 
full intermediate team and are able to serve as ‘control’ 
areas, although each hospital-based service would have 
continued with its own internal service developments. We 
have previously reported no impact on metabolic control 
or hospitalisation rates in spite of full implementation of 
the service.6
Deidentified electronic Secondary Uses Service data 
for across Cambridgeshire were obtained for recorded 
inpatient tariff between April 2007 (ie, 2 years before 
the DICI contract commenced) and March 2012. Prac-
tice, patient age, elective/non-elective status,Interna-
tional Classification of Diseases 10th revision (ICD10) 
and Health Related Group coding were included in the 
dataset. Diabetes was considered present if E10– E14 was 
in any ICD10 field and, as the primary cause of admis-
sion if coded in the first field.14 15 Inpatient payments 
recorded in 2008–2009 were used as baseline, to compare 
with that recorded in 2011–2012 as the end of the inter-
vention period. Using the Sarkadi et al method, the 
mean and SD for normal distributions before and after 
the intervention can be estimated. The ‘health gain’ 
is defined as the area between the two distribution 
curves on the right side, where the distribution density 
after intervention is lower (the shaded area in online 
supplementary figure 1 left). In our study, ‘health gain’ 
represents the proportion of patients with reduced inpa-
tient payments between the baseline and intervention 
period. The reduction in commissioner payments reflects 
reduced needs in care and thus improvement in health.
Sarkadi’s method has outlined ways to calculate the 
impact when the two distributions have the same SD, or 
when the follow-up group has smaller mean and smaller 
SD at the same time. However, we have noticed when 
using real data that the follow-up group might have 
smaller mean but larger SD To accommodate this situa-
tion; we have modified the Sarkadi’s method as described 
in online supplementary technical appendix and online 
supplementary figure 1. The health gain distributions are 
presented in online supplementary figure 2 to illustrate 
the health gains at a population level.
In addition to the normal distribution originally used 
in Sarkadi’s method, three other distributions, gamma 
distribution, log-normal distribution and normal distri-
bution of log-transferred payment data, were attempted 
to fit the data. The goodness-of-fit statistics, Akaike infor-
mation criterion (AIC), Bayesian information criterion 
(BIC) and log-likelihood were tested over four distribu-
tions and the distribution with the minimum AIC, BIC 
and maximum log-likelihood was chosen as the final 
distribution to examine the impact.
Bootstrapping is used to obtain a P value for the prob-
ability of health gain larger than zero. We randomly 
sampled data points with replacements from the original 
data separately for the baseline and follow-up, so that 
we obtain bootstrapped data with the same numbers of 
data points. These are used to obtain an estimation of the 
health gain after perturbation. This process is repeated 
1000 times. The probability of observing estimations 
less than or equal to zero is calculated, and used as the 
approximation of the P value for testing whether health 
gain is significantly larger than zero.
No personal identifiers were released to researchers, 
and all subsequent analyses were conducted on anony-
mised datasets. Age data were provided allowing analyses 
to be undertaken above and below the median age (70 
years) to assess any related variation.
The work had approval from the Cambridgeshire 
research ethics committee as part of a wider service eval-
uation and, as such, was deemed not to require personal 
informed consent.
All analyses were conducted in R (V.3.1).
results
The sample size of inpatient payment records during the 
baseline and the intervention periods in each region is 
presented in table 1. The inpatient payments during the 
baseline period and the intervention period are shown 
in table 2 by area and age group. In each area and age 
group, a lower individual median inpatient payment was 
more likely to be found in the intervention period.
Figure 1 shows  the distribution of the inpatient 
payments in people with type 2 diabetes in the baseline 
and intervention periods. This illustrates the effect of the 
integrated care intervention, as the left-moving curve in 
the intervention period indicates the potential inpatient 
payment saving at a population level.
Four distributions (normal distribution, gamma 
distribution, log-normal distribution and normal 
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Table 1 Sample size of the inpatient payment records
East Cambridge and Fenland Huntingdonshire Great Cambridge
<70 years ≥70 years <70 years ≥70 years <70 years ≥70 years
2008–2009 2012 2028 1494 1664 1575 1329
2011–2012 2431 2756 1871 1990 2004 1823
distribution of log-transformed payment data) were 
attempted to fit the payment data as presented in online 
supplementary table 1. The normal distribution of 
log-transformed payment data was chosen to estimate the 
impact on the intervention for its minimum AIC and BIC 
and its maximum log-likelihood.
The magnitude of the intervention at the population 
level is presented in table 3. Significant ‘health gain’ 
was observed both in the intervention area and control 
areas, especially among patients aged less than 70 years. 
In the intervention area, East Cambridge and Fenland, 
7.69% (95 CI 5.89% to 9.74%) and 2.05% (0.72% to 
4.13%) of patients aged less than 70 years and aged 
more than 70 years, respectively, had a reduced inpatient 
payment, compared with the population in the baseline 
period. In Huntingdonshire, the ‘health gain’ was 6.90% 
(5.63% to 8.68%) and 4.62% (2.22% to 7.23%) among 
patients aged less than 70 years and patients aged more 
than 70 years, respectively. In Greater Cambridge, the 
‘health gain’ was 7.59% (5.63% to 9.94%) and 2.49% 
(1.46% to 4.58%) among patients aged less than 70 years 
and patients aged more than 70 years, respectively.
To allow comparisons, the estimated impact, based on 
a normal distribution, is presented in online supplemen-
tary table 2. In the intervention area, East Cambridge and 
Fenland, 2.74% (1.29% to 5.81%) of patients aged more 
than 70 years had a reduced inpatient payment, compared 
with the population in the baseline period. In one of the 
control areas, Greater Cambridge, ‘health gain’ was also 
observed in 3.20% (1.77% to 7.20) of patients aged less 
than 70 years and 4.14% (2.27% to 7.86) patients aged 
more than 70 years, respectively. Significant ‘health gain’ 
was not identified within the population in Huntingdon-
shire over the study period.
dIscussIOn
We have used a novel way, calculating the total health gain 
(proportion of people with reduced inpatient payments) 
assuming a Gaussian distribution, to assess the results 
of integrated care in the diabetic population of areas in 
Cambridgeshire through a population lens. The study 
revealed a possible effect of the new integrated care 
approach on inpatient payments, as 7.7% of patients aged 
less than 70 years and 2.1% of patients aged more than 70 
years had reduced inpatient payments in the intervention 
area, East Cambridge and Fenland. However, reductions 
were also seen in the control areas, in Huntingdonshire, 
6.9% of patients aged less than 70 years and 4.6% of 
patients aged less than 70 years had reduced inpatient 
payment; in Greater Cambridge, 7.6% of patients aged 
less than 70 years and 2.5% of patients aged less than 70 
years had reduced inpatient. The 95% CIs overlapped 
across the three areas, so we have not shown any differ-
ences between the areas.
Significant improvements in diabetes care can occur 
with multifaceted interventions16 including disease 
management in the USA17 and integrated care in 
Germany,18 and these can be associated with reductions 
in hospital costs.19 The integrated care intervention was 
successfully implemented across the area, with positive 
patient experience, improved practice nurse clinical 
confidence and early reports of clinical benefit.13 20 It 
is therefore surprising that although some (small) posi-
tive benefit was observed in the intervention area, the 
return on the investment of £250 000 was not greater and 
possibly less than in one of the control areas. Elsewhere, 
diabetes integrated care interventions have generally 
been more effective within single providers or in contexts 
where multiple primary care organisations work with a 
single specialist provider under an integrated insurance 
scheme.6 The integrated care intervention carried out 
in ECF followed a nurse-led service with one of the goals 
reducing referrals (ie, payments) to hospital outpatients. 
This philosophy, rather than progressing to truly inte-
grated services, carried through the intervention period, 
although as part of a wider programme that included 
‘vertical integration’ developments. It was perhaps to be 
expected that attempts at creating such greater ‘vertical’ 
integration in information management, clinical gover-
nance, budget and overall management were agreed, but 
not implemented, actions more achievable within a single 
organisation. There was an attempt to create a single 
equal partner network model21 nearing the end of the 
intervention period, but this was not funded by the local 
commissioners.
The failure to implement integrated information 
management almost certainly contributed to communi-
cation and integration difficulties. Most integrated care 
initiatives attempt to include data sharing22 and this was 
not possible within the local information governance 
arrangements. This was noticed by the patients and was 
a source of frustration. Interestingly, integration was 
perceived as happening when there was one person 
‘fronting up’ for all those involved. Case management 
has been proposed as one approach to integration, and 
requires the case manager to corral and coordinate the 
services for a given individual.17
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Whether our findings are due to a unique set of circum-
stances or expected as part of a three-compartment model 
(primary care, intermediate care and secondary care) is 
unclear, but there are indications that the circumstances 
are not special. There are calls for more integration and 
less fragmentation in healthcare,22 yet the evidence on 
what works in England is limited.23 24 The latest changes 
in commissioning in the English NHS, with emphasis on 
the need to consider ‘Any qualified Provider’ in service 
delivery, and associated market procurement approaches, 
could well impair the quality of diabetes care while 
increasing overall cost, if the experience here is repro-
duced elsewhere.
Similarly, as a ‘natural experiment’, it was not possible 
to measure the impact of integrated care on inpatient 
payments at an individual level. Instead, we estimated 
the proportion of the population showing ‘health gain’ 
(reduced inpatient payments) from the integrated care 
intervention by using the distribution curve of inpatient 
payment. Although the method was within the conceptual 
framework proposed by Sarkardi, some modifications to 
the methodology were made to overcome methodolog-
ical drawbacks, for example, requiring the same SD for 
two Gaussian curves: something unlikely to occur in real 
scenarios. We believe this revised method would be more 
applicable to evaluate the ‘health gain’ for interventions 
at a population level.
There are limitations to our study. This was not a 
randomised trial, so any changes could be due to secular 
trends, although we do compare with the two other areas 
in Cambridgeshire. The data depended on the complete-
ness of the coding of diabetes, and there being no system-
atic change in coding over this time period. We found that 
at least one provider had high diabetes ascertainment.10 
Data access restrictions prevented adjustment for some 
important covariables. As the data used was record based 
rather than individual based, repeat inpatient records 
were unable to be linked; however, the record-based data 
still provide a range of plausible estimations. Moreover, 
within a relatively fixed diabetes population served by a 
local ‘closed’ inpatient care and tariff system, the likeli-
hood for patients having a second hospital admission 
would still be relatively low (although higher than those 
without diabetes).10 In other words, inpatient payments at 
two time points are considered completely independent 
of each other. We acknowledge that this current analysis 
still yields findings subject to confounding bias unable 
to be measured in this study. The ‘impact’ observed in 
our study may therefore only reflect measured changes 
in the DICI and ‘control’ regions, respectively, rather 
than due to the DICI itself, as the DICI care model was 
not randomly assigned. As a result of data access restric-
tions, it is not possible in this study to identify those with 
multiple admissions (and payments) that would provide 
‘redundant information’. The application of bootstrap-
ping ignoring such redundant information might lead 
to a misapplication of Sarkadi’s tool and might inadver-
tently increase the false-positive rate: something to be 
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Figure 1 Using the normal (Gaussian) curve to demonstrate the distribution of inpatient payment in people with type 2 
diabetes and possible effects of an integrated care on the curve.The differences between the respective areas under the curve 
are shaded. Health gains for participants with lower inpatient payment. Left top: East Cambridge and Fenland, <70 years; right 
top: East Cambridge and Fenland, ≥70 years. Left middle: Great Cambridge,<70 years; right middle: Great Cambridge, ≥70 
years. Left bottom: Huntingdonshire, <70 years; right bottom: Huntingdonshire, ≥70 years.
Table 3 The estimated absolute ‘health gain (impact)’ after the intervention by age and region: estimation based on normal 
distribution of log-transferred inpatient payment data
Impact, % 95% CI, % P value (bootstrapping)
East Cambridge and Fenland <70 years 7.69 (5.89 to 9.74) 0
≥70 years 2.05 (0.72 to 4.13) 0.044796
Huntingdonshire <70 years 6.90 (5.63 to 8.68) 0
≥70 years 4.62 (2.22 to 7.23) 0.001300
Greater Cambridge <70 years 7.59 (5.63 to 9.94) 0
≥70 years 2.49 (1.46 to 4.58) 0.037096
The health gain (impact) was defined as percentage of people with type 2 diabetes and hospital admission having reduced inpatient payment 
after the integrated care at population level.
taken into consideration when interpreting the findings 
in this study. There might be other potential unidentified 
confounders in this study and evaluation seeking other 
confounding factors would be possible in future studies 
with more variables in the dataset including a way to iden-
tify those confounders.
In conclusion, we have applied a modified novel 
strategy to measure ‘health gain’ associated with an inte-
grated care intervention at a population level. We found 
that there were no differences in inpatient payments. Our 
findings suggest that irrespective of the ideal principles 
behind integration, linking multiple health providers to 
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deliver population-based diabetes care is complex and 
improvements in health outcomes remain difficult to 
achieve.
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